2014
DOI: 10.3844/ajisp.2014.10.13
|View full text |Cite
|
Sign up to set email alerts
|

A Comparative Study of Anti-Phosphatidyl Inositole Antibodies in Patients With Myocardial Infarction and Healthy Subjects

Abstract: Immune system and inflamation is widely known to play a key role in the development and progression of cardiovascular diseases. Anti-Phospholipid (aPL) antibodies may act in the induction of immunological response leading to the development of Acute Myocardial Infarction (AMI). Anti-Phosphatidyl Inositole (PI) Antibody (Ab) has been seen in various diseases including rheumatoid arthritis, systemic lupus erythematosus and anti-phospholipid antibody syndrome. Although there are a few studies on the association o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 18 publications
0
3
0
Order By: Relevance
“…The Cardiovascular Disease (CVD) is one of the most important causes of mortality in the world and the burden of this disease is increasing in all developing countries (Ebrahsim and Davey-Smith, 2001; Boutayeb and Boutayeb, 2005). Smoking, high blood pressure, lipid disorder, diabetes mellitus (Almdal et al, 2004;Tang et al, 2004;Murphy et al, 2009;Amarenco et al, 2010;Willey et al, 2009), infectious disease such as mycoplasma pneumonia (Pourahmad et al, 2009), low serum adiponectin level (Shojaie et al, 2009a) and inflammation (Jahromi et al, 2010a), low serum level of Annexin-V (Shojaie et al, 2009b) and antiphospholipid antibodies (Jahromi et al, 2013a;2013b;2013c;Shojaei et al, 2011;Jahromi et al, 2010b;2014), are fundamental risk factors of heart disease. In a cohort study, the increased one standard deviation in systolic blood pressure was associated with 35% increment of risk of CVD (Hadaegh et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…The Cardiovascular Disease (CVD) is one of the most important causes of mortality in the world and the burden of this disease is increasing in all developing countries (Ebrahsim and Davey-Smith, 2001; Boutayeb and Boutayeb, 2005). Smoking, high blood pressure, lipid disorder, diabetes mellitus (Almdal et al, 2004;Tang et al, 2004;Murphy et al, 2009;Amarenco et al, 2010;Willey et al, 2009), infectious disease such as mycoplasma pneumonia (Pourahmad et al, 2009), low serum adiponectin level (Shojaie et al, 2009a) and inflammation (Jahromi et al, 2010a), low serum level of Annexin-V (Shojaie et al, 2009b) and antiphospholipid antibodies (Jahromi et al, 2013a;2013b;2013c;Shojaei et al, 2011;Jahromi et al, 2010b;2014), are fundamental risk factors of heart disease. In a cohort study, the increased one standard deviation in systolic blood pressure was associated with 35% increment of risk of CVD (Hadaegh et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, there is a correlation between exercise and the expression of other cytokines, e.g. endurance training may affect the serum levels of TNFα and IFNγ in men [47].…”
Section: Discussionmentioning
confidence: 99%
“…There are different pathways that play roles in atherosclerotic plaque formation. Genetics and environmental factors are important ones such as family history, obesity, hyperlipidemia, diabetes mellitus, inflammation and hypertension ( Shea et al, 1984 ; Godfrey et al, 1994 ; Thom et al, 2006 ; Shojaie et al, 2009 ; Shojaie et al, 2009 ; Jahromi et al, 2013 ; Jahromi et al, 2014 ).…”
Section: Introductionmentioning
confidence: 99%